Automated insulin delivery (AID) systems– which integrate an insulin pump, continuous glucose monitoring (CGM), and a sophisticated algorithm to automate insulin delivery– have revolutionized the man- agement of type 1 diabetes (T1D). AID systems aim to improve gly- caemic control and reduce the burden of manual management, and numerous clinical trials have now demonstrated their safety and effi- cacy in different populations with T1D.
Omnipod 5 in children and adolescents with type 1 diabetes: Improved outcomes with fewer boluses
Marigliano, Marco;Maffeis, Claudio;
2025-01-01
Abstract
Automated insulin delivery (AID) systems– which integrate an insulin pump, continuous glucose monitoring (CGM), and a sophisticated algorithm to automate insulin delivery– have revolutionized the man- agement of type 1 diabetes (T1D). AID systems aim to improve gly- caemic control and reduce the burden of manual management, and numerous clinical trials have now demonstrated their safety and effi- cacy in different populations with T1D.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
O5_DOM2025.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Non specificato
Dimensione
555.32 kB
Formato
Adobe PDF
|
555.32 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
